ConnectiveRX announced Jan. 24 that Chief Executive Officer Jim Corrigan stepped down and company founder Harry Totonis will once again lead the Whippany-based pharmaceutical services provider as CEO.
Along with Genstar Capital, Totonis founded ConnectiveRx in 2015 and served as CEO for more than five years. He transitioned to chairman of the board in 2021.
“Harry’s long standing experience as a founding member of ConnectiveRx combined with his deep expertise in the health technology and financial sectors position him to best lead the organization through this pivotal stage of accelerated growth. His relationships with the team will allow a seamless and smooth transition,” Eli Weiss, managing partner of Genstar Capital, said in a statement.
Weiss added, “We are thankful to Jim Corrigan for his leadership over the last two years and wish him well in his next endeavor.”
Before founding the company, Totonis was president and CEO of Surescripts, an e-prescription company based in Virginia, where he was instrumental in digitizing the prescription process, ConnectiveRX said. He also has served in executive positions at companies such as MasterCard and Booz Allen Hamilton.
ConnectiveRx, a finalist in the NJBIZ 2022 Business of the Year awards, serves pharmaceutical manufacturers, health care providers and nearly 100 million patients each year through its technology-driven platform that streamlines the prescription medication process.
The company has an additional base in Pittsburgh, Pa.